Sugar spheres: A versatile excipient for oral pellet medications with modified release kinetics

Pharmaceutical Technology Europe

Volumn 18, Issue 4, 2006, Pages 35-41

  Werner, Detlef ^a  

^a Hanns G Werner GmbH and Co KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; EXCIPIENT; STARCH MICROSPHERE; SUGAR;

ARTICLE; DRUG COATING; DRUG INDUSTRY; DRUG PELLET; DRUG RESEARCH; DRUG SOLUBILITY; DRUG STABILITY; PARTICLE SIZE; POROSITY; QUALITATIVE ANALYSIS; SURFACE PROPERTY; SUSTAINED RELEASE FORMULATION; SUSTAINED RELEASE PREPARATION;

EID: 33645743837     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. D. Werner, Pharma International, 2, 70-77 (1984).
2. U. Hofer, in W. Fahrig and U. Hofer, Eds, Die Kapsel (Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany, 1983) pp 83-111.
3. W.A. Ritschel, Angewandte Biopharmazie (Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany, 1973) pp 396-423.
4. P. Langguth and G. Fricker, Wunderli-Allenspach, Biopharmazie (Wiley-VCH Verlag, Weinheim, Germany, 2004) pp 367 ff.
5. I. Ghebre-Sellassie, Pharmaceutical Pelletization Technology (Marcel Dekker Inc., New York, NY, USA, 1989).
6. K.H Bauer et al., Überzogene Arzneiformen (Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany, 1988) pp 40-49.
7. K. Knop and B.C. Lippold, Pharm. Ind. 51(3), 302-309 (1989).
8. M. Niskanen et al., Pharm. Technol. Int. 2(10), 22-28 (1990)
9. and Pharm. Technol. Int. 2(11), 32-36 (1990).
10. E. Nürnberg and J. Wunderlich, Pharm. Technol. Int. 11(2), 41-47 (1999)
11. and Pharm. Technol. Int 11(3), 30-34 (1999).
12. P.C. Schmidt and K. Weyhing, Dtsch. Apoth. Ztg. 144(18), 2082-2086 (2004).
13. United States Pharmacopeial Convention, National Formulary, 23rd edition, Rockville, MD, USA (2005).
14. Council of Europe: European Pharmacopoeia, 5th edition, Brussels, Belgium (2005).
15. D. Werner, Pharm. Technol. Int. 8(9), 30-36 (1996).
16. Anonymous, Pharm. Ind. 61(5), 483 (1999).
17. R. Chopra et al., Eur. J. Pharm. Biopharm. 53(3), 327-333 (2002).
18. European Pharmacopoeia, Method 2.9.16 "Flowability", 5th edition, Brussel, Belgium (2005).
19. DIN Deutsches Institut für Normung: DIN ISO 787 Teil 11 Bestimmung des Stampfvolumens und der Stampfdichte", Beuth Verlag, Berlin, Germany (1983).
20. L. Hellen et al., Pharm. Technol. Int. 5(2), 38-48 (1993).
21. International Organization for Standardization, Standard ISO 3310-1:2000, Test Sieves, Technical Requirements and Testing, Part 1: Test Sieves of Metal Wire Cloth, 4th edition, Geneva (2000).
22. D. Werner, Laborpraxis 23(1), 42-47 (1999).
23. H. Kanerva, Pharm. Ind. 55(8), 775-779 (1993).
24. H. Lindner and P. Kleinebudde, Pharm. Ind. 55(7), 694-701 (1993).
25. G. Heinicke and J.B. Schwartz, Pharm. Dev. Technol. 9(4), 359-367 (2004).
26. C. Christiansen and B.W. Müller, Pharm. Ind. 64(4), 390-397 (2002).
27. L.S.C. Wan and T. Jeyabalan, Acta Pharm. Technol. 32 (4), 197-199 (1986).
28. U. Körber and T. Moest, Acta Pharm. Technol. 36(1), 33-35 (1990).
29. P. Schultz and P. Kleinebudde, Pharm. Ind. 57(4), 323-328 (1995).
30. Bundesministerium für Gesundheit und soziale Sicherung: "Deutsches Arzneibuch", Entwurf für eine Monographie 2.9.N2: "Abrieb von Pellets und Granulaten", Methode I (Wirbelschichtapparatur) und Methode II (Schwingapparatur); Deutscher Apotheker Verlag, Stuttgart (not published yet).
31. Anonymous, "Texture Analysis Application Overview - Tablets, Granules and Pellets", (Stable Micro Systems, Godalming, UK, 2005).
32. F. Balszuweit, T. Wagner and P. Kleinebudde, Pharm. Ind. 62(12), 985-991 (2000).
33. A.R. Gupte, Acta Pharm. Technol. 22(3), 153-168 (1976).
34. P.A. Webb, An Introduction to the Physical Characterization of Materials by Mercury Intrusion Porosimetry with Emphasis on Reduction and Presentation of Experimental Data (Micromeritics, Norcross, UK 2001).
35. A.M. Juppo et al., Eur. J. Pharm. Biopharm. 44(2), 205-214 (1997).
36. F. El Saleh and P. Kleinebudde, Pharm. Technol. Int. 10(11), 18-26 (1998).
37. W.A. Ritschel and A. Bauer-Brandl, Die Tablette: Handbuch der Entwicklung, Herstellung und Qualitätssicherung, Auflage 2nd edition (Editio Cantor Verlag, Aulendorf, Germany, 2002) pp 28.
38. W.G. Schmidt, "Kontrollierte Wirkstoff-Freisetzung aus Matrixpellets" Ph.D thesis, Freie Universität Berlin, Germany (1992).
39. M.P. Flament et al., Pharm. Technol. Int. 6(2), 19-25 (1994).
40. T. Beckert, "Verpressen von magensaftresistent überzogenen Pellets zu zerfallenden Tabletten", Ph.D thesis, Eberhard-Karls-Universität, Tübingen, (1995).
41. R. Bodmeier, Eur. J. Pharm. Biopharm. 43(1), 1-8 (1997).
42. M. Türkoglu, H. Varol and M. Celikok, Eur. J. Pharm. Biopharm. 57(2), 279-286 (2004).
43. J.M. Newton, Pharm. Technol. Int. 12(5), 40 (2000)
44. and D. Werner, Letter to the Editor, Pharm. Technol. Int. 12(9), 10 (2000).